Literature DB >> 8580294

Mass screening for cervical cancer in Norway: evaluation of the pilot project.

T Bjørge1, A B Gunbjørud, O A Haugen, G B Skare, C Tropé, S O Thoresen.   

Abstract

The Norwegian Department of Health and Social Affairs initiated a national screening program for cervical cancer in 1990, with all women aged 25 to 70 years to be offered cervical screening every three years. During the first three years of the program (November 1991-October 1994), all spontaneous cervical cytology in Norway was recorded at the Norwegian Cancer Registry. In addition, women in the counties of Vestfold and Sør-Trøndelag were invited individually to be screened. The aim of the present study was principally to evaluate the organization aspects of a nationwide, population-based screening program for cervical cancer in Norway. Special attention was paid to the coverage, the attendance rate, and the cytologic findings in the two-county study area. A total of 1,581,379 Pap smears were recorded from November 1991 to October 1994. Most smears were taken from women under age 30 years (31.7 percent). About 25 percent of the women aged 25 to 29 years had more than one normal smear. In the study area, a coverage of about 71 percent in the age group 25 to 69 years was achieved. The pilot project also has shown that it is possible to recruit elderly women into screening. However, no difference was noted between the study and the reference area with regard to findings per smear of precursor lesions (CIN 3, modified SNOMED coding system). The experiences from three years of recording and the implementation of the pilot project have provided useful guidelines for the national screening which began in January 1995.

Entities:  

Mesh:

Year:  1995        PMID: 8580294     DOI: 10.1007/bf00054154

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  13 in total

1.  Second International Workshop on the Epidemiology of Cervical Cancer and Human Papillomaviruses.

Authors:  F X Bosch; N Munoz; K V Shah; A Meheus
Journal:  Int J Cancer       Date:  1992-09-09       Impact factor: 7.396

2.  Report on a Workshop of the UICC Project on Evaluation of Screening for Cancer.

Authors:  A B Miller; J Chamberlain; N E Day; M Hakama; P C Prorok
Journal:  Int J Cancer       Date:  1990-11-15       Impact factor: 7.396

3.  Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes.

Authors:  E Lăără; N E Day; M Hakama
Journal:  Lancet       Date:  1987-05-30       Impact factor: 79.321

4.  Potential contribution of screening to cancer mortality reduction.

Authors:  M Hakama
Journal:  Cancer Detect Prev       Date:  1993

5.  European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.

Authors:  D Coleman; N Day; G Douglas; E Farmery; E Lynge; J Philip; N Segnan
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

6.  Survival trend after invasive cervical cancer diagnosis in Sweden before and after cytologic screening. 1960-1984.

Authors:  H O Adami; J Pontén; P Sparén; R Bergström; L Gustafsson; L G Friberg
Journal:  Cancer       Date:  1994-01-01       Impact factor: 6.860

Review 7.  Screening for cervical cancer: is there a place for incorporating tests for the human papillomavirus?

Authors:  V Beral; N E Day
Journal:  IARC Sci Publ       Date:  1992

8.  Use of pap-smears in a population without a mass screening program.

Authors:  S Forsmo; H Buhaug; H Stalsberg
Journal:  Acta Obstet Gynecol Scand       Date:  1994-11       Impact factor: 3.636

9.  Incidence, survival and mortality in cervical cancer in Norway, 1956-1990.

Authors:  T Bjørge; S O Thoresen; G B Skare
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

10.  Cervical mass screening in Norway--510,000 smears a year.

Authors:  T Bjørge; A B Gunbjørud; F Langmark; G B Skare; S O Thoresen
Journal:  Cancer Detect Prev       Date:  1994
View more
  2 in total

1.  Infection and cervical neoplasia: facts and fiction.

Authors:  Wael I Al-Daraji; John Hf Smith
Journal:  Int J Clin Exp Pathol       Date:  2008-04-28

2.  Cervical cancer in women under 30 years of age in Norway: a population-based cohort study.

Authors:  Brit Helene Gravdal; Stefan Lönnberg; Gry Baadstrand Skare; Gerhard Sulo; Tone Bjørge
Journal:  BMC Womens Health       Date:  2021-03-18       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.